Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Polycythemia Vera 4 Lung Neoplasms 4 Ovarian Neoplasms 3 Myeloproliferative Disorders 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thymic aplasia 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1

Interventions

Everolimus 9 Temozolomide 7 Sunitinib 7 Specimen Handling 4 Octreotide 4 Magnetic Resonance Spectroscopy 4 Fluorouracil 4 Capecitabine 4 lutetium Lu 177 dotatate 3 Leucovorin 3 sargramostim 2 montanide ISA 51 2 incomplete Freund's adjuvant 2 cabozantinib 2 Thalidomide 2 Streptozocin 2 Sorafenib 2 Oxaliplatin 2 Irinotecan 2 Injections 2 Endoscopic Ultrasound-Guided Fine Needle Aspiration 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Colony-Stimulating Factors 2 Bevacizumab 2 surufatinib 1 sapanisertib 1 recombinant interferon alpha 2b-like protein 1 pentetreotide 1 pasireotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Phlebotomy × Clear all

NCT03741517 2022-05-18

Biomarker Study of Pancreatic Neuroendocrine Tumours

Uppsala University

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡